IPASS: DATA FROM AN ONGOING STUDY OF THE TOLERABILITY AND EFFECTIVENESS OF INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF MALE HYPOGONADISM

被引:0
|
作者
Zitzmann, M. [1 ]
Hanisch, J. U. [2 ]
Mattern, A. [3 ]
机构
[1] Univ Clin Munster, Ctr Reprod Med & Androl, Munster, Germany
[2] Bayer Vital GmbH, Leverkusen, Germany
[3] Bayer Schering Pharma AG, Berlin, Germany
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:97 / 97
页数:1
相关论文
共 50 条
  • [1] IPASS: DATA FROM AN ONGOING STUDY OF THE TOLERABILITY AND EFFECTIVENESS OF INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF MALE HYPOGONADISM
    Zitzmann, M.
    Lianisch, J. U.
    Martern, A.
    JOURNAL OF MENS HEALTH, 2009, 6 (04) : 400 - 400
  • [2] IPASS: Data from an Ongoing Study of the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in 937 Men.
    Zitzmann, M.
    Mattern, A.
    Hanisch, J. U.
    Jones, T. H.
    Maggi, M.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [3] IPASS: A Study on the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in a Worldwide Sample of 1,438 Men
    Zitzmann, Michael
    Mattern, Andreas
    Hanisch, Jens
    Gooren, Louis
    Jones, Hugh
    Maggi, Mario
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 (02): : 579 - 588
  • [4] Re: IPASS: A Study on the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in a Worldwide Sample of 1,438 Men Editorial Comment
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2013, 189 (01): : 250 - 251
  • [5] IPASS: Interim data from a large international study of injectable testosterone undecanoate on sexual health and other parameters of male hypogonadism
    Zitzmann, M.
    Hanisch, J. U.
    Mattern, A.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 : 398 - 399
  • [6] Injectable testosterone undecanoate for the treatment of hypogonadism
    Corona, Giovanni
    Maseroli, Elisa
    Maggi, Mario
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (13) : 1903 - 1926
  • [7] INJECTABLE TESTOSTERONE UNDECANOATE FOR THE TREATMENT OF HYPOGONADISM
    Maseroli, E.
    Coruna, G.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 245 - 245
  • [8] TREATMENT OF MALE HYPOGONADISM WITH INJECTABLE TESTOSTERONE UNDECANOATE: OUTCOME META-ANALYSIS STUDY
    Corona, G.
    Maseroli, E.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 12 - 12
  • [9] Testosterone undecanoate in the treatment of male hypogonadism
    Edelstein, Daniel
    Basaria, Shehzad
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (12) : 2095 - 2106
  • [10] COST EFFECTIVENESS OF TESTOSTERONE UNDECANOATE INJECTION AS TESTOSTERONE THERAPY FOR MALE HYPOGONADISM
    Ferguson, J.
    Gilmour, I.
    Church, N.
    Priaulx, J.
    JOURNAL OF MENS HEALTH, 2009, 6 (03) : 251 - 251